Is your doctor a marijuana user? Maybe you should ask.

Join Our Mailing List

327518caf4de6ca81321ea8b469a3d42Reefer Madness Redux

By Michael Lawrence Langan MD

Cannabis, also known as marijuana and by numerous other names, is a preparation of the Cannabis plant intended for use as a psychoactive drug or medicine.

The main psychoactive part of cannabis is tetrahydrocannabinol (THC); it is one of 483 known compounds in the plant, including at least 84 other cannabinoids, such as cannabidiol (CBD), cannabinol (CBN), and tetrahydrocannabivarin (THCV).

Source: https://en.wikipedia.org/wiki/Cannabis_(drug)

***

Devotee of Medical Marijuana

[Clandestine Grow Lab at Home]

***

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com

OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:

Risk Management, Liability Insurance, and Asset Protection Strategies for Doctors and Advisors: Best Practices from Leading Consultants and Certified Medical Planners™  Risk Management, Liability Insurance, and Asset Protection Strategies for Doctors and Advisors: Best Practices from Leading Consultants and Certified Medical Planners™

***

White House Rejects Petition To Legalize Marijuana

Initiative to Stop State Interference Fails

[By Staff Reporters]

Join Our Mailing List

The White House has rejected several marijuana legalization petitions, one of which called on the federal government to stop interfering with state marijuana legalization efforts.

The ONDCP

“As a former police chief, I recognize we are not going to arrest our way out of the problem,” wrote Gil Kerlikowske, director of the Office of National Drug Control Policy, in a statement released late last Friday. “We also recognize that legalizing marijuana would not provide the answer to any of the health, social, youth education, criminal justice, and community quality of life challenges associated with drug use.”

The statement came in response to a petition submitted by retiredBaltimore narcotics officer Neill Franklin as part of the White House’s “We The People” project, an effort to allow ordinary Americans to gain the attention of policymakers through an online portal at the White House website. Any petition garnering 5,000 signatures within 30 days of submission is guaranteed a response from the White House;Franklin’s petition received more than 17,000.

Failed Prohibition Policies

“It’s maddening that the administration wants to continue failed prohibition polices that do nothing to reduce drug use and succeed only in funneling billions of dollars into the pockets of the cartels and gangs that control the illegal market,” said Franklin, who serves as executive director of advocacy group Law Enforcement Against Prohibition, in a statement released last Saturday.

Franklin’s petition comes as federal prosecutors have escalated enforcement actions against medical marijuana dispensary owners inCalifornia, vowing to shutter state-licensed businesses and threatening landlords with property seizures for violating federal drug laws.Franklinhas also called on the president to remember his campaign promise not to waste government resources interfering with state-regulated marijuana dispensaries.

Rejected by the White House

The White House’s rejection statement was directed at seven other marijuana-related petitions, which together garnered more than 150,000 signatures. One such petition, which called for marijuana to be regulated in a manner similar to alcohol, received almost 75,000 signatures.

“Like many, we are interested in the potential marijuana may have in providing relief to individuals diagnosed with certain serious illnesses,” the White House wrote in its official response. “That is why we ardently support ongoing research into determining what components of the marijuana plant can be used as medicine. To date, however, neither the FDA nor theInstituteofMedicinefound smoked marijuana to meet the modern standard for safe or effective medicine for any condition.”

Read the full response from the White House below:

When the President took office, he directed all of his policymakers to develop policies based on science and research, not ideology or politics. So our concern about marijuana is based on what the science tells us about the drug’s effects.

The National Institute of Health

According to scientists at the National Institutes of Health — the world’s largest source of drug abuse research — marijuana use is associated with addiction, respiratory disease, and cognitive impairment. We know from an array of treatment admission information and Federal data that marijuana use is a significant source for voluntary drug treatment admissions and visits to emergency rooms. Studies also reveal that marijuana potency has almost tripled over the past 20 years, raising serious concerns about what this means for public health -– especially among young people who use the drug because research shows their brains continue to develop well into their 20’s. Simply put, it is not a benign drug.

Like many, we are interested in the potential marijuana may have in providing relief to individuals diagnosed with certain serious illnesses. That is why we ardently support ongoing research into determining what components of the marijuana plant can be used as medicine. To date, however, neither the FDA nor the Institute of Medicine have found smoked marijuana to meet the modern standard for safe or effective medicine for any condition.

A Balanced National Drug Control Strategy

We recognize that legalizing marijuana would not provide the answer to any of the health, social, youth education, criminal justice, and community quality of life challenges associated with drug use.

That is why the President’s National Drug Control Strategy is balanced and comprehensive, emphasizing prevention and treatment while at the same time supporting innovative law enforcement efforts that protect public safety and disrupt the supply of drugs entering our communities. Preventing drug use is the most cost-effective way to reduce drug use and its consequences inAmerica. And, as we’ve seen in our work through community coalitions across the country, this approach works in making communities healthier and safer. We’re also focused on expanding access to drug treatment for addicts. Treatment works. In fact, millions of Americans are in successful recovery for drug and alcoholism today. And through our work with innovative drug courts across the Nation, we are improving our criminal justice system to divert non-violent offenders into treatment.

Assessment

Our commitment to a balanced approach to drug control is real. This last fiscal year alone, the Federal Government spent over $10 billion on drug education and treatment programs compared to just over $9 billion on drug related law enforcement in theU.S.

Thank you for making your voice heard. I encourage you to take a moment to read about the President’s approach to drug control to learn more.

Source: Dawn Dearden

More Info:

Drug Enforcement Administration

Section Chief, Public Affairs

Phone 202 307-2402

Fax 202 353-1628

dawn.n.dearden@usdoj.gov

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com

OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:

Product DetailsProduct DetailsProduct Details

On the New Pot Health Policy in NJ?

Join Our Mailing List

It’s Medicinal – Man!

By Staff Reporters

Did you know that in January 2010, New Jersey became the 14th state in the nation to legalize marijuana use for certain chronic illnesses?

Other states where the use of medical marijuana is permitted include Alaska, California, Colorado, Hawaii, Maine, Michigan, Montana, Nevada, New Mexico, Oregon, Rhode Island, Vermont, and Washington; around a dozen more states are weighing pending bills.

Jersey is Toughest State

The New Jersey law is the most restrictive in the nation and authorizes prescribed marijuana for only a handful of chronic illnesses, such as multiple sclerosis, cancer, glaucoma, epilepsy, Crohn’s disease, AIDS, muscular dystrophy and Lou Gehrig’s disease. Unlike other states, physicians in New Jersey will not be able to prescribe medical marijuana for anxiety, headaches, or chronic pain.

Dispensaries

According to reports, the state of New Jersey plans to authorize six dispensaries, and patients will receive identification cards authorizing them to purchase the drug. They will not be able to grow their own marijuana or use it in public, however. And, individuals without a prescription will still be subject to criminal prosecution if caught in possession of marijuana.

http://www.hcplive.com/oncology/articles/Marijuana?utm_source=Listrak&utm_medium=Email&utm_term=%2foncology%2farticles%2fMarijuana&utm_campaign=Legalizing+Medical+Marijuana

Assessment

Do you support the use of medical marijuana? If you are a doctor that lives in a state where medical marijuana is legalized, have you prescribed it to any patients? If you live in a state where medical marijuana is not legalized, do you want it to be? What about you patients, out there?

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com

OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:

Product DetailsProduct DetailsProduct Details